CWM
IPSC icon

CIBC World Markets’s Century Therapeutics IPSC Stock Holding History

CIBC World Markets’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,384
Closed -$4.94K – 1745
2025
Q1 		$4.94K Buy
+10,384
New +$7.8K ﹤0.01% 1836

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CIBC World Markets's IPSC Position: Q2 2025 in Review

CIBC World Markets sold out of Century Therapeutics (IPSC) in Q2 2025, closing a stake of 10,384 shares — an estimated $4.94K sold.

CIBC World Markets first reported a position in IPSC in Q1 2025 and held it in 1 quarter. The position peaked at $4.94K in Q1 2025. 65 funds tracked by Wall St. Rank hold IPSC as of Q2 2025.

  • CIBC World Markets reported no remaining Century Therapeutics position as of Q2 2025 after selling out during the quarter.
  • CIBC World Markets sold 10,384 Century Therapeutics shares in Q2 2025, an estimated $4.94K.
  • CIBC World Markets first reported a position in Century Therapeutics in Q1 2025 and held it in 1 quarter.
  • CIBC World Markets's Century Therapeutics position peaked at $4.94K in Q1 2025.
  • 65 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.